Anticoagulants

Revolade 50® Eltrombopag Tablets
Eltrombopag 50mg
- Composition
- Eltrombopag 50mg
- Dosage form
- Tablet
- Pack size
- Strip of 7 Tablet
- Manufacturer
- Novartis
- Also known as
- Promacta, Eltrombopag Viatris
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Revolade 50 mg contains eltrombopag and is used to manage low platelet counts in certain conditions, including immune thrombocytopenia, chronic hepatitis C-related thrombocytopenia and acquired severe aplastic anaemia, where indicated.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Anticoagulants
Anticoagulants
Anticoagulants
Anticoagulants
